Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

AI’s Dark Horses: 3 Underestimated Stocks in the AI Revolution

Almost invariably, whenever someone brings up AI stock opportunities, Nvidia (NASDAQ:NVDA) is the name you’ll most likely hear. If not that, then it could be…

7 High-Yield Dividend Stocks With High-Upside Potential

High-yield dividend stocks with potential for upside gains is essentially the Tony Robbins of market opportunities. Robbins gives you a big smile, a warm hug…

Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now

Ever had the experience of befriending the schoolyard bully? That’s sort of the underlying catalyst behind hedge fund favorite stocks. As professionally managed pools of…

DKNG Stock Alert: What Flutter Entertainments’ NYSE Listing Means for DraftKings

Although DraftKings now has a U.S.-listed competitor in Flutter Entertainment, stakeholders of DKNG stock don’t necessarily need to panic.

Why Is Palisade Bio (PALI) Stock Up 100% Today?

Palisade Bio is benefiting from a trio of positive news items, including encouraging preclinical data. Now PALI stock is blasting higher.